Bradsaúde beats Q2 2026 forecasts, stock drops 8.5%

Bradsaúde beat Wall Street expectations for both profit and revenue in Q2 2026, yet its stock fell 8.51% to $14.72 in after-hours trading from a closing price of $16.09. The company reported earnings per share of 0.3144, exceeding the forecast of 0.2712, and revenue of $651.99 million, surpassing estimates of $620.5 million. Membership grew to 13.6 million with 229,000 net additions, while net profit rose 24.8% year-over-year. Investors appeared focused on cautious forward guidance and competitive pressures despite strong operational results. The stock trades below its 52-week midpoint, and management provided no specific revenue or profit guidance for the year, though it expects stable claims ratios and continued double-digit revenue growth.